Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.82 - $9.26
Previous CloseN/A
Volume261.88K
Average Volume (3M)1.08M
Market Cap
$1.62B
Enterprise ValueN/A
Total Cash (Recent Filing)$448.35M
Total Debt (Recent Filing)$56.68M
Price to Earnings (P/E)100.0
Beta1.06
Next Earnings
Aug 07, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding102,468,710
10 Day Avg. Volume773,607
30 Day Avg. Volume1,075,964
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)2.36
Price to Sales (P/S)0.00
P/FCF Ratio15.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$6.52Price Target Upside50.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
---
GoodRx Holdings News
PremiumCompany Announcements
GoodRx Reports Strong Q1 2025 Results
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe profitability beat was impressive, with adjusted EBITDA coming in 4% better than expected, driven largely by sales and marketing efficiencies.
Market PositionGoodRx's marketplace is evolving into more of a utility, reducing competitive risks and strengthening its staying power.
Strategic PartnershipsThe company is focusing on closer partnerships with retail pharmacies, which is their highest strategic priority.
Bears Say
Pharma Manufacturing SolutionsPharma Manufacturer Solutions revenue grew by 17% year-over-year but missed expectations by 5% to 7%.
Prescription PricingPrescription pricing increased across the platform, which drove a miss on overall MACs.
Subscription RevenuesSubscription revenues were slightly below expectations, driven by a decline in subscribers.
---
Ownership Overview
11.18% Insiders
12.94% Mutual Funds
0.44% Other Institutional Investors
65.12% Public Companies and
Individual Investors
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $3.82 and its highest was $9.26 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $1.62B.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Aug 07, 2025 which is in 87 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on May 07, 2025. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.095 by -$0.005.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.1.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 102,468,710 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.09 in its last earnings report, missing expectations of $0.095. Following the earnings report the stock price went up 11.873%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
---
GoodRx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.52 (50.93% Upside)
$6.52 (50.93% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 919.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
Last 30 Days ▲ 1.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.97%
12-Months-Change
Fundamentals
Return on Equity
4.43%
Trailing 12-Months
Asset Growth
-12.63%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
---
GDRX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a mixed outlook with several positive developments such as revenue growth, strong financial performance, and expanding manufacturer solutions. However, challenges like the Rite Aid bankruptcy, pressure on monthly active consumers, and macroeconomic uncertainties present potential setbacks.Read More>---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$6.52
▲(50.93% Upside)
Technical Analysis
---